Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Using multi-year field trials and transcriptome-wide allele-specific expression analyses, they showed maternal inbred choice can speed seed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results